Davis on Clipper's 'Camel' Picks
Clipper fund manager Christopher Davis says the recent downturn offered a rare opportunity to buy high-quality firms that can weather the harshest environments.
Clipper fund manager Christopher Davis says the recent downturn offered a rare opportunity to buy high-quality firms that can weather the harshest environments.
Dan Culloton: Let's talk about some of the other names that have shown up on the portfolio. At least I noticed in Clipper (CFIMX), which I interpret to be some of your highest conviction ideas, that Diageo (DEO) showed up in there in recent months. I wonder what attracts your firm to that stock.
Christopher Davis: I think maybe what I can do is talk about a category of stocks that is in Clipper, and we sometimes call them "camels." You think about a camel as something you can rid through the desert. It doesn't need water, it can go a long way. In the chaos that we've been in, it's true that there are probably some cyclical firms, including some in financials, that could get very cheap. If you buy them right, you get them near the bottom. We also say the ones that do best in the recovery are the ones that just barely kept their lips above water.
<TRANSCRIPT>
We generally don't try to invest like that, but we recognize that in a recovery we will lag those that called that just right. On the other hand, it's a dangerous game if they're too early.
Another category of companies that got very inexpensive were what Peter Lynch used to call the "stalwarts." He used say that you sometimes only get one chance in a decade, sometimes even one chance in a generation, to buy really good companies at 10 or 12 times earnings. The Johnson & Johnsons (JNJ), the Diageos, Procter & Gamble (PG), Colgate-Palmolive (CL). These are some of the great, durable companies with terrific balance sheets, with no need for financing, very durable businesses, high dividend yields.
Well, here's the math. If you can buy a company that can grow 10% a year, if you can buy that company at a 10 multiple and pick up a 3% dividend along the way.... And over time that multiple, let's say over a decade that multiple ends up at 15, you get a staggering return.
Because you get the 10% growth of the business, you get the 50% multiple reevaluation, plus you get the dividend yield. Well, that works out about an 18% or an 18.5% compound. For a business that's only growing 10%.
So we think a lot about, in this sort of world, having the opportunity to buy those types of businesses at very low multiples.
Dan: Where does Loews fit into that?
Christopher: Loews (L) is in a second category. Now to be clear, this is Loews the Tisch's holding company as opposed to Lowe's the home improvement shop. And we have a second category that we think of in the world that we're in, which is those companies where the temperament, the balance sheet, the disposition and discipline of management is that they're able to take advantage - they have a record of taking advantage - of chaos. And of course the best example is Berkshire-Hathaway (BRK.A). They went in this with $50 billion more in cash and a temperament to be able to look for opportunities in the chaos.
Well, the Tisches and the Loews management team have had that record. Buying pipeline companies during the Enron debacle, getting into the tobacco business - early and controversial - realizing enormous value for that before spinning it off.
So they have a record of being opportunistic. They certainly had the balance sheet and the valuation to be able to do so. Now I don't know what they'll do. I mean, their shares treated at discount to simply the sum of the parts, so I think they have lots of opportunities.
But I think I would put that in a different category than sort of the high quality global growth companies and put it in this category of opportunistic entrepreneurial, well-capitalized, conservatively-oriented but opportunistic management teams.
Dan: Is this a case where you could go out and buy the publicly traded subsidiaries of Loews and maybe still do as well and still benefit from their management expertise?
Christopher: I don't think so. I think that in most cases in this sort of company, you want to be invested where the entrepreneurial money, where the insider, the management family investment is. That really aligns your interests. They own Loews Corp. So when you get into thing like tracking stocks or the independent pieces, we look at them in terms of valuation and we add them up to the parts, and that's how we get the fact that the parent is actually cheaper than the sum of the parts.
But our feeling is, we'd rather be invested in the same entity as they are, at the holding company level rather than in the subsidiaries.
[END OF RECORDING]
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.